[1] |
CHEN Yijun, LIU Yuhang, DUAN Haibo, WANG Xiongjun.
Functional and mechanistic of AGPAT5 in liver cancer
[J]. China Oncology, 2024, 34(9): 838-847.
|
[2] |
CAO Xiaoshan, YANG Beibei, CONG Binbin, LIU Hong.
The progress of treatment for brain metastases of triple-negative breast cancer
[J]. China Oncology, 2024, 34(8): 777-784.
|
[3] |
HUANG Sijie, KANG Xun, LI Wenbin.
Clinical research progress of intrathecal therapy in the treatment of leptomeningeal metastasis
[J]. China Oncology, 2024, 34(7): 695-701.
|
[4] |
SHEN Jie, FENG Xiaoshuang, WEN Hao, ZHOU Changming, MO Miao, WANG Zezhou, YUAN Jing, WU Xiaohua, ZHENG Ying.
Metastasis patterns and survival analysis of 572 patients with metastatic cervical cancer: a hospital-based real world study
[J]. China Oncology, 2024, 34(4): 361-367.
|
[5] |
LI Xiaohui, ZHAO Jiaxu, PENG Haibao, ZHANG Ye, ZENG Rui, CHI Yudan.
Effects of HMGA2 on migration and proliferation of leptomeningeal metastatic melanoma
[J]. China Oncology, 2024, 34(4): 389-399.
|
[6] |
OUYANG Fei, WANG Yang, CHEN Yu, PEI Guoqing, WANG Ling, ZHANG Yang, SHI Lei.
Construction of the prediction model of breast cancer bone metastasis based on machine learning
[J]. China Oncology, 2024, 34(10): 903-914.
|
[7] |
ZHAO Junxiu, ZHU Yi, SONG Xiaoyu, ZHE Chao, XIAO Yuhan, LIU Yunduo, LI Linhai, XIAO Bin.
Circ-0007766 acts as a miR-1972 sponge to promote breast cancer cell migration and invasion via upregulation of HER2
[J]. China Oncology, 2024, 34(10): 915-930.
|
[8] |
LIU Xuerou, YANG Yumei, ZHAO Qian, RONG Xiangyu, LIU Wei, ZHENG Ruijie, PANG Jinlong, LI Xian, LI Shanshan.
Research progress on the role of glutamine metabolism-related proteins in tumor metastasis
[J]. China Oncology, 2024, 34(1): 97-103.
|
[9] |
YANG Ziyi, GU Bingxin, XU Xiaoping, SONG Shaoli.
Comparison of 18F-FDG and 68Ga-FAPI PET/CT in the diagnosis of lung metastasis in different malignant tumors
[J]. China Oncology, 2023, 33(9): 829-833.
|
[10] |
XUE Liqiong, GUO Ye, CHEN Libo.
Expert consensus on the management of adverse events in patients receiving targeted agents for advanced thyroid cancer (2023 edition)
[J]. China Oncology, 2023, 33(9): 879-888.
|
[11] |
CHEN Man, ZENG Feiyan, LI Qingqing, LI Hongdan, LIN Yansong, FENG Ping.
A meta-analysis of the efficacy of 99Tc-MDP alone and in combination with 89SrCl2 in the treatment of bone metastases
[J]. China Oncology, 2023, 33(8): 751-767.
|
[12] |
YE Junling, ZHENG Xiaoying, GUO Xinjian, CHEN Ruihui, YANG Liu, GOU Xiaodan, JIANG Hanmei.
A study on mechanism of lncRNA-mediated SNHG5/miR-26a-5p/MTDH signal axis promoting metastasis of colorectal cancer
[J]. China Oncology, 2023, 33(7): 673-685.
|
[13] |
DU Shuxiang, ZHAO Yingzhi, ZHANG Xuetao, WANG Tao, LUO Jingyu, ZHANG Wei, WU Gang.
Analysis of group 12a lymph node metastasis at different sites of gastric adenocarcinoma and its risk factors
[J]. China Oncology, 2023, 33(6): 597-604.
|
[14] |
YUAN Xinyue, YAO Yao, CHENG Shuai, ZHENG Xin, ZHANG Yuan.
Clinical study on high-risk factors for contralateral lymph node metastasis in unilateral papillary thyroid carcinoma
[J]. China Oncology, 2023, 33(6): 619-628.
|
[15] |
QU Ning, WANG Yuting, MA Ben, WANG Yu.
Advances in basic research, clinical diagnosis and treatment of thyroid cancer in 2022
[J]. China Oncology, 2023, 33(5): 423-430.
|